Last reviewed · How we verify
XW10172
At a glance
| Generic name | XW10172 |
|---|---|
| Sponsor | XWPharma |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Valiloxybate (XW10172 MR) Efficacy and Safety Parkinson's Disease Study (PHASE2)
- Pharmacokinetics, Safety, and Tolerability of Various XW10172 Oral Formulations in Healthy Adult Volunteers (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- XW10172 CI brief — competitive landscape report
- XW10172 updates RSS · CI watch RSS
- XWPharma portfolio CI